AACR cordially invites you to the AACR Annual Meeting 2012 taking place Saturday, March 31-Wednesday, April 4, 2012, at McCormick Place in Chicago, Illinois.
As always, this AACR Annual Meeting will highlight the best and latest findings in all major areas of cancer research. Investigators in a wide variety of disciplines will attend and benefit from hearing about these advances and networking with their colleagues. Cancer researchers continue to make incredible strides and breakthroughs, with an impact on global health. The theme of the AACR Annual Meeting 2012, “Accelerating Science: Concept to Clinic,” reflects this amazing progress and emphasizes the synergy between basic, clinical, and translational research that will continue to lead to effective cancer therapies and prevention strategies.
The program will feature daily plenary sessions, major symposia, minisymposia, forums, educational sessions, methods workshops, poster sessions, “Current Concepts and Controversies in Organ Site Research” sessions, and an exciting new series of sessions focused on “Current Concepts and Controversies in Diagnostics, Therapeutics, and Prevention.” We are also excited to be planning two sessions featuring presentations of new clinical data and for the first time, there is a poster session on “Clinical Trials in Progress.” In addition, there is a track devoted to regulatory science and policy.
With the accelerating pace of discoveries in the basic, translational, and clinical sciences, due in large part to the advent of new technologies, cancer researchers are making rapid progress that is having significant patient benefit. It is clear that in the near future, even greater opportunities for the prevention, management, and cures for all types of cancer will abound. We are confident that attending the AACR Annual Meeting will give you renewed energy, inspiration, and focus in your work. If you would like to receive Annual Meeting updates, please email marketing@aacr.org to join the AACR mailing list.
For more info, click here.
